Gujarat FDCA Forms Special Flying Squads To Combat Sale Of Adulterated, Counterfeit & Spurious Medicines

Mumbai: In a groundbreaking initiative to tackle the sale of adulterated, counterfeit, and spurious medicines, the Gujarat Food and Drug Control Administration (FDCA) has formed special flying squads for the first time in the state’s history. These squads, comprising two enforcement teams each, are led by an assistant commissioner and include senior drug inspectors and drug inspectors. This strategic move has been approved by the state government to enhance surveillance and monitoring across the pharmaceutical supply chain.

Dr HG Koshia, the FDCA Commissioner, hailed the formation of these squads as a “landmark move” in ensuring the safety and efficacy of medicines available in the market. “In order to curb the clandestine activity involving the sale of adulterated, counterfeit, and spurious medicines, Gujarat FDCA has set up a special flying squad of two enforcement teams each headed by an assistant commissioner and comprising senior drug inspectors and drug inspectors for the first time in Gujarat for effective surveillance and monitoring,” stated Dr. Koshia.

The enforcement teams have been meticulously selected from a pool of 175 officers within the Gujarat FDCA’s enforcement department, based on their competence and track record. These squads are tasked with monitoring the entire supply chain, which includes over 6,000 manufacturers and around 55,000 wholesalers and retailers across Gujarat.

The primary objective of these squads is to conduct regular and surprise inspections, ensure compliance with drug safety regulations, and take stringent actions against violators. By doing so, the FDCA aims to safeguard public health and maintain the integrity of the pharmaceutical market.

Dr. Koshia emphasized the importance of this initiative, stating, “The formation of these squads marks a significant step towards ensuring that only safe and genuine medicines reach the consumers. We are committed to maintaining the highest standards of drug safety and will take all necessary measures to eliminate any threats posed by adulterated and counterfeit drugs.”

Related Posts

  • Pharma
  • September 16, 2024
  • 37 views
All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

New Delhi: The National Medical Commission (NMC) has initiated the process of registration of all MBBS doctors eligible to practice in India on a recently launched portal, as a part of…

  • Pharma
  • September 16, 2024
  • 52 views
ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

New Delhi: In a significant stride towards strengthening India’s clinical research ecosystem, the Indian Council of Medical Research (ICMR) has formalized Memorandum of Agreements (MoAs) with multiple sponsors under its Network…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

Balaji Action Hsopital now equipped with Robotic System to Revolutionize Surgery

Balaji Action Hsopital now equipped with Robotic System to Revolutionize Surgery

1680 Onerex Cough Syrup Bottles Loaded In A Luxury Car Seized, One Arrested

1680 Onerex Cough Syrup Bottles Loaded In A Luxury Car Seized, One Arrested

DCC Once Again Sensitises State Regulators To Submit NSQ Data On Time

DCC Once Again Sensitises State Regulators To Submit NSQ Data On Time

DRI seizes alprazolam tablets worth Rs 30 lakh

DRI seizes alprazolam tablets worth Rs 30 lakh